But like you said, it could be CVI deliberately pushing down the pps. At 2c, IMU will be value at $160M (even with the 1B shares from the CN it will be only $180M) with $131M in available funds and HER-Vaxx completed Ph2 clinical trial with good result, PD1-Vaxx about to commence Ph2 clinical trial, OASIS commenced Ph1 clinical trial for nearly 16 months and excellent clinical trial updates for VAXINIA and Azer-Cel.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.2¢ | $267.3K | 20.57M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 788815 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 13241534 | 29 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |